| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Jovanovic D, Kandic B, Kr... |
Neka nasa iskustva u lecenju dusevnih bolesnika dietilamidom lizergicn... |
Vojno-sanit.Pregl. |
1960 |
| Uyeno ET |
Lysergic acid diethylamide and dominance behaviour of the squirrel mon... |
Arch Int Pharmacodyn |
1967 |
| Uyeno ET |
Lysergic acid diethylamide and sexual dominance behaviour of the male ... |
Int J Neurospsychiat |
1967 |
| Uyeno ET |
Effects of mescaline and psilocybin on dominance behaviour of the rat |
Arch Int Pharmacodyn |
1967 |
| Newman B, Dihrberg A, Sul... |
Thin layer chromatography of lysergic acid diethylamide (LSD_, N,N dim... |
Abstr. Papers, Am. C... |
1968 |
| Booij J |
Vraagstukken rondom de psychotherapie |
Ned. T. Geneesk. |
1968 |
| Snyder SH, Faillace LA, W... |
DOM STP, a new hallucinogenic drug, and DOET: effects in normal subjec... |
Am J Psychiatry |
1968 |
| Smith DE |
The Psychotomimetic Amphetamines with Special Reference to DOM (STP) T... |
Journal of Psychedel... |
1969 |
| Malleson N |
Acute adverse reactions to LSD in clinical and experimental use in the... |
Brit. J. Psychiat. |
1971 |
| Hawks DV |
The dimensions of drug dependence in the United Kingdom |
Int. J. Addict. |
1971 |
| Wallach MB, Friedman E, G... |
2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examin... |
J. Pharmacol. exp. T... |
1972 |
| Ronald T. Coutts and Jerr... |
The Synthesis of Analogs of the Hallucinogen 1-2,5-Dimethoxy-4-methylp... |
Can. J. Chem. |
1973 |
| Marquis WJ, Tilson HA, Re... |
Effects of amphetamine(A), LSD, psilocybin (P), and DOM on schedule-co... |
Federation Proceedin... |
1973 |
| Cheng HC, Long JP, Barfkn... |
Cardiovascular effects of 2, 5-dimethoxy-4-methylamphetamine DOM, STP |
J Pharmacol Exp Ther |
1973 |
| Ronald T. Coutts and Jerr... |
The Synthesis of Some Analogs of the Hallucinogen 1-2,5-Dimethoxy-4-me... |
Can. J. Chem. |
1973 |
| Nichols DE, Barfknecht CF... |
Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methyl... |
J Med Chem |
1974 |
| Angrist B, Rotrosen J, Ge... |
Assessment of Tolerance to the Hallucinogenic Effects of DOM |
Psychopharmacologia |
1974 |
| Srám RJ, Zudova Z, Goetz ... |
The Mutagenic Effect Of Lysergic Acid Diethylamide. II. Dominant Letha... |
Mutation Research |
1974 |
| Ronald T. Coutts and Jerr... |
The Synthesis of Four Possible in vitro Metabolites of the Hallucinoge... |
Can. J. Chem. |
1974 |
| Beaton JM, Benington F, B... |
Stereospecific actions of 2,5-dimethoxy-4-methylamphetamine DOM on col... |
Br J Pharmacol |
1976 |
| Friedman E, Lambert GA, B... |
2,5-Dimethoxy-4-methylamphetamine (DOM)- a central component of its ca... |
Eur J Pharmacol |
1978 |
| Silverman PB, Ho BT |
Stimulus Properties of DOM: Commonality with Other Hallucinogens |
Psychopharmacology |
1978 |
| Brandon JM |
Failure of indomethacin and d-2-bromolysergic acid diethylamide to mod... |
J. Endocr. |
1978 |
| Glennon RA, Rosecrans JA,... |
Hallucinogens As A Discriminative Stimuli: Generalizations Of Dom To A... |
Life Sci. |
1979 |
| Shannon HE |
MDA and DOM: Substituted Amphetamines that do not Produce Amphetamine-... |
Psychopharmacology |
1980 |
| Commissaris RL, Lyness WH... |
Effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methyla... |
Federation Proceedin... |
1981 |
| Davis EW |
Out of the vast array of species in the plantkingdom — variously estim... |
Botanical Museum Lea... |
1983 |
| Glennon RA, Young R, Jacy... |
DOM-Stimulus Generalization to LSD and Other Hallucinogenic Indolealky... |
European Journal of ... |
1983 |
| Mokler DJ, Commissaris R... |
Naloxone Alters the Effects of LSD, DOM and Quipazine on Operant Behav... |
Pharmacology Biochem... |
1984 |
| Mokler DJ, Rech RH |
Behavioral Effects of Intracerebroventricular Administration of LSD, D... |
Pharmacology Biochem... |
1984 |
| Adams LM, Geyer MA |
Effects of DOM and DMT in a proposed animal model of hallucinogenic ac... |
Prog Neuropsychophar... |
1985 |
| Glennon RA, Hauck AE |
Mechanistic studies on DOM as a discriminative stimulus |
Pharmacol Biochem Be... |
1985 |
| Dimpfel W, Spuler M, Nich... |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... |
Psychopharmacology (... |
1989 |
| Perez-Reyes M, Burstein S... |
Antagonism of marihuana effects by indomethacin in humans |
Life Sci |
1991 |
| Screaton GR, Singer M, Ca... |
Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse |
Lancet |
1992 |
| Glennon RA |
MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethy... |
Pharmacol Biochem Be... |
1993 |
| Aulakh CS, Mazzola-Pomiet... |
Role of various 5-HT receptor subtypes in mediating neuroendocrine eff... |
J Pharmacol Exp Ther |
1994 |
| Lehmann ED, Thom CH, Crof... |
Delayed severe rhabdomyolysis after taking 'ecstasy' |
Postgrad Med J |
1995 |
| Volz HP, Kieser M |
Kava-kava extract WS 1490 versus placebo in anxiety disorders--a rando... |
Pharmacopsychiatry |
1997 |
| Cunningham M |
Ecstasy-induced rhabdomyolysis and its role in the development of acut... |
Intensive Crit Care ... |
1997 |
| Fiorella D, Helsley S, Ra... |
Further investigations of the interactions of antipsychotics with the ... |
Neuropharmacology |
1997 |
| Krishnan A, Brown R |
Plain abdominal radiography in the diagnosis of the 'body packer' |
J Accid Emerg Med |
1999 |
| Akhondzadeh S, Naghavi HR... |
Passionflower in the treatment of generalized anxiety: a pilot double-... |
J Clin Pharm Ther |
2001 |
| Knoller N, Levi L, Shosha... |
Dexanabinol (HU-211) in the treatment of severe closed head injury: a ... |
Crit Care Med |
2002 |
| Solomon PR, Adams F, Silv... |
Ginkgo for memory enhancement: a randomized controlled trial |
JAMA |
2002 |
| Goldberg L, Elliot DL, Ma... |
Drug testing athletes to prevent substance abuse: background and pilot... |
J Adolesc Health |
2002 |
| Sue YM, Lee YL, Huang JJ |
Acute hyponatremia, seizure, and rhabdomyolysis after ecstasy use |
J Toxicol Clin Toxic... |
2002 |
| Eckler JR, Chang-Fong J, ... |
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabol... |
Pharmacol Biochem Be... |
2003 |
| McCabe SE, Boyd CJ, Young... |
Mode effects for collecting alcohol and tobacco data among 3rd and 4th... |
Addict Behav |
2005 |
| Scott-Ham M, Burton FC |
Toxicological findings in cases of alleged drug-facilitated sexual ass... |
Journal of clinical ... |
2005 |
| Padmanabhan R, Hildreth A... |
A prospective, randomised, controlled study examining binaural beat au... |
Anaesthesia |
2005 |
| Biederman J, Swanson JM, ... |
Efficacy and safety of modafinil film-coated tablets in children and a... |
Pediatrics |
2005 |
| Safarinejad MR, Hosseini ... |
Safety and efficacy of tramadol in the treatment of premature ejaculat... |
J Clin Psychopharmac... |
2006 |
| Alatrash G, Majhail NS, P... |
Rhabdomyolysis after ingestion of 'foxy,' a hallucinogenic tryptamine ... |
Mayo Clin Proc |
2006 |
| Zarate CA, Singh JB, Carl... |
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... |
Arch Gen Psychiatry |
2006 |
| Furey ML, Drevets WC |
Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... |
Arch Gen Psychiatry |
2006 |
| Robertson JR, Raab GM, Br... |
Addressing the efficacy of dihydrocodeine versus methadone as an alter... |
Addiction |
2006 |
| Gray MT |
Freedom and resistance: the phenomenal will in addiction |
Nurs Philos |
2007 |
| Walsh C |
Drugs and human rights: private palliatives, sacramental freedoms andc... |
The International Jo... |
2010 |
| Baggott MJ, Siegrist JD, ... |
Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4... |
Plos One |
2010 |
| Krupitsky E, Nunes EV, Li... |
Injectable extended-release naltrexone for opioid dependence: a double... |
Lancet |
2011 |
| Mithoefer MC, Wagner MT, ... |
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assi... |
J Psychopharmacol |
2011 |
| Petroczi A, Nepusz T, Cro... |
New non-randomised model to assess the prevalence of discriminating be... |
Subst Abuse Treat Pr... |
2011 |
| Bar-Or D, Salottolo KM, O... |
A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Eva... |
Eur Urol |
2011 |
| MacLean KA, Johnson MW, G... |
Mystical experiences occasioned by the hallucinogen psilocybin lead to... |
J Psychopharmacol |
2011 |
| Oehen P, Traber R, Widmer... |
A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymeth... |
J Psychopharmacol |
2013 |
| Mohamed AD, Lewis CR |
Modafinil increases the latency of response in the Hayling Sentence Co... |
PLoS One |
2014 |
| Kamour A, James D, Lupton... |
Patterns of presentation and clinical features of toxicity after repor... |
Clin Toxicol (Phila) |
2014 |
| Savage KM, Stough CK, Byr... |
Kava for the treatment of generalised anxiety disorder (K-GAD): study ... |
Trials |
2015 |
| O'Connor AD, Padilla-Jone... |
Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison... |
J Med Toxicol |
2015 |
| Flindall I, Leff DR, Good... |
Structured cues or modafinil for fatigue amelioration in clinicians? A... |
Surgery |
2015 |
| Racz J, Csak R, Toth KT, ... |
Veni, vidi, vici: The appearance and dominance of new psychoactive sub... |
Drug Alcohol Depend |
2016 |
| Hope VD, Cullen KJ, Smith... |
Is the recent emergence of mephedrone injecting in the United Kingdom ... |
Euro Surveill |
2016 |
| Kalasho A, Vibe Nielsen S |
5-MeO-DALT; a novel designer drug on the market causing acute delirium... |
Acta Anaesthesiol Sc... |
2016 |
| Grunebaum MF, Galfalvy HC... |
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression:... |
Am J Psychiatry |
2017 |
| Danforth AL, Grob CS, Str... |
Reduction in social anxiety after MDMA-assisted psychotherapy with aut... |
Psychopharmacology (... |
2018 |
| Uenoyama R, Miyazaki T, H... |
The characteristic response of domestic cats to plant iridoids allows ... |
Sci Adv |
2021 |
